VRD: Clinical Trials

3 trials of VRD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Phase 11Recruiting 1
Phase 31Not yet recruiting 1

Follow VRD: new trials by email Literature Review of VRD trials Research Report on VRD

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells
Isatuximab, VRD - Multiple Myeloma
Phase 2 / Phase 3Not yet recruitingThe Affiliated People's Hospital of Ningbo University152027-01-012026-10-02
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma
anti-BCMA CAR-T, VRd - Multiple Myeloma
Phase 2Active not recruitingInstitute of Hematology & Blood Diseases Hospital, China402023-04-042025-08-03
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
Chidamide+VRD, VRD - Multiple Myeloma
Phase 1 / Phase 2RecruitingThe First Affiliated Hospital of Soochow University502019-07-152019-07-19

Conditions studied

Multiple Myeloma (3)

Sponsors

Institute of Hematology & Blood Diseases Hospital, China (1)  ·  The Affiliated People's Hospital of Ningbo University (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (2)

Results publications

PMID 41759038